1Y Annualised Return
▲46.57%
3Y Annualised Return
▼-0.03%
5Y Annualised Return
▲41.58%
Fredun Pharmaceuticals Stock Performance
|
|
|
Fredun Pharmaceuticals Company background
Founded in: 1987
Managing director: Fredun N Medhora
Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations. Since 1993, D N Pharmas operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy. The Company has an unique range of products, from niche formulations , antidiabetics to the latest antiretroviral and anti Hypertensive products. It supplies finished formulations to over 42 Countries globally. It is associated with many Governments of different countries which have also realised the need for robust and consistent healthcare systems.The Company was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, drysyrups and ointments. It then set up a formulation unit at Palghar (Thane District), Maharashtra, which commenced commercial production in Aug.94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind.In Apr.96, the company came out with a public issue to register its products in the overseas market for exports to partfinance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of companys turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal, Tanzaniya, Uganda Sri Lanka.In 2013, Company launched 36 new products and filed 60 new products for registration. It launched a herbal dietary supplement in Africa. During 2015, three new granulation departments were introduced to the existing two departments. It launched 19 new products under the Cosmeceuticals OEM Division in 2023. It introduced 14 new products in the pet pharmaceuticals line, with another 36 in the works. It launched 16 products into the Pet Treat and Nutritional Supplement category.
Fredun Pharmaceuticals Share Price Today
As of 11 Nov 2025, Fredun Pharmaceuticals share price is ₹1710.2. The stock opened at ₹1628.8 and had closed at ₹1628.8 the previous day. During today’s trading session, Fredun Pharmaceuticals share price moved between ₹1,628.85 and ₹1,710.25, with an average price for the day of ₹1669.55. Over the last 52 weeks, the stock has recorded a low of ₹635.00 and a high of ₹1,785.00. In terms of performance, Fredun Pharmaceuticals share price has increased by 146.8% over the past six months and has increased by 46.57% over the last year.
Fredun Pharmaceuticals SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹10,03,271 in 5 years with a gain of ₹7,03,271 (+234.42%)
Fredun Pharmaceuticals Fundamental
Market Cap (in crs)
769.09
Face Value
10
Turnover (in lacs)
232.87
Key Metrics
Qtr Change %
Near 52W High of ₹1785.00
61.4
Dividend yield 1yr %
Low in industry
0.04
Fredun Pharmaceuticals Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
1710.25
Current Price
Day EMA5
1,585.20
Day EMA10
1,586.30
Day EMA12
1,583.10
Day EMA20
1,554.80
Day EMA26
1,526.80
Day EMA50
1,413.60
Day EMA100
1,236.70
Day EMA200
1,058.70
Day SMA5
1,565.80
Day SMA10
1,610.30
Day SMA20
1,581.60
Day SMA30
1,508.80
Day SMA50
1,398.70
Day SMA100
1,172.30
Day SMA150
1,019.00
Day SMA200
937.40
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 12450 Rs | 12450 Rs |
Week Rs | 10788 Rs | 10788 Rs |
Month Rs | 13369 Rs | 13369 Rs |
Resistance & Support
1,628.85
Pivot
Resistance
First Resistance
1,628.85
Second Resistance
1,628.85
Third Resistance
1,628.85
Support
First Support
1,628.85
Second support
1,628.85
Third Support
1,628.85
Relative Strength Index
62.05
Money Flow Index
56.82
MACD
56.32
MACD Signal
74.46
Average True Range
82.90
Average Directional Index
38.09
Rate of Change (21)
14.43
Rate of Change (125)
132.81
Fredun Pharmaceuticals Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
160.62 | 776.87 | 154.06 | 312.4 | 160.89 | -2.36% | -7.42% | -9.84% | -47.82% | -6.97% | 1.86% | 29.81 | 40.46 | 1.80 | |
243.35 | 848.73 | 154.01 | 329.7 | 243.35 | -8.58% | -4.10% | 1.33% | -4.90% | 294.09% | 0.00% | 19.73 | 40.46 | 10.96 | |
81.27 | 817.23 | 74.25 | 122.85 | 81.54 | -7.79% | -1.17% | 0.26% | 0.00% | 0.00% | 0.92% | 21.11 | 40.46 | 2.50 | |
278.90 | 816.12 | 219 | 449 | 277.30 | -1.88% | -7.14% | 7.72% | -14.29% | 43.06% | 0.89% | 9.20 | 40.46 | 2.15 | |
1,189.50 | 797.26 | 802 | 1870 | 1,156.80 | -2.70% | -7.07% | 9.20% | -18.19% | 216.36% | 0.09% | 32.85 | 40.46 | 2.06 | |
142.40 | 757.41 | 90.78 | 147.7 | 142.50 | 2.25% | 10.18% | 0.00% | 0.00% | 0.00% | 0.00% | 36.99 | 42.56 | 3.77 |
Fredun Pharmaceuticals Share Price FAQs
How to buy Fredun Pharmaceuticals shares?
You can easily buy Fredun Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Fredun Pharmaceuticals ?
The 52-week high and low of Fredun Pharmaceuticals share price is ₹1785 and ₹635 as of 11/11/2025.
Please be aware that Fredun Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.
Invest in Fredun Pharmaceuticals